Dimensions of control for subthreshold oscillations and spontaneous firing in dopamine neurons

An oscillating reaction network with an exact closed form solution in the time domain

BACKGROUND

Oscillatory behavior is critical to many life sustaining processes such as cell cycles, circadian rhythms, and notch signaling. Important biological functions depend on the characteristics of these oscillations (hereafter, oscillation characteristics or OCs): frequency (e.g., event timings), amplitude (e.g., signal strength), and phase (e.g., event sequencing). Numerous oscillating reaction networks have been documented or proposed. Some investigators claim that oscillations in reaction networks require nonlinear dynamics in that at least one rate law is a nonlinear function of species concentrations. No one has shown that oscillations can be produced for a reaction network with linear dynamics. Further, no one has obtained closed form solutions for the frequency, amplitude and phase of any oscillating reaction network. Finally, no one has published an algorithm for constructing oscillating reaction networks with desired OCs.

RESULTS

This is a theoretical study that analyzes reaction networks in terms of their representation as systems of ordinary differential equations. Our contributions are: (a) construction of an oscillating, two species reaction network [two species harmonic oscillator (2SHO)] that has no nonlinearity; (b) obtaining closed form formulas that calculate frequency, amplitude, and phase in terms of the parameters of the 2SHO reaction network, something that has not been done for any published oscillating reaction network; and (c) development of an algorithm that parameterizes the 2SHO to achieve desired oscillation, a capability that has not been produced for any published oscillating reaction network.

CONCLUSIONS

Our 2SHO demonstrates the feasibility of creating an oscillating reaction network whose dynamics are described by a system of linear differential equations. Because it is a linear system, we can derive closed form expressions for the frequency, amplitude, and phase of oscillations, something that has not been done for other published reaction networks. With these formulas, we can design 2SHO reaction networks to have desired oscillation characteristics. Finally, our sensitivity analysis suggests an approach to constructing a 2SHO for a biochemical system.

Novel and flexible parameter estimation methods for data-consistent inversion in mechanistic modelling

Predictions for physical systems often rely upon knowledge acquired from ensembles of entities, e.g. ensembles of cells in biological sciences. For qualitative and quantitative analysis, these ensembles are simulated with parametric families of mechanistic models (MMs). Two classes of methodologies, based on Bayesian inference and population of models, currently prevail in parameter estimation for physical systems. However, in Bayesian analysis, uninformative priors for MM parameters introduce undesirable bias. Here, we propose how to infer parameters within the framework of stochastic inverse problems (SIPs), also termed data-consistent inversion, wherein the prior targets only uncertainties that arise due to MM non-invertibility. To demonstrate, we introduce new methods to solve SIPs based on rejection sampling, Markov chain Monte Carlo, and generative adversarial networks (GANs). In addition, to overcome limitations of SIPs, we reformulate SIPs based on constrained optimization and present a novel GAN to solve the constrained optimization problem.

Neuronal population models reveal specific linear conductance controllers sufficient to rescue preclinical disease phenotypes

Preclinical drug candidates are screened for their ability to ameliorate in vitro neuronal electrophysiology, and go/no-go decisions progress drugs to clinical trials based on population means across cells and animals. However, these measures do not mitigate clinical endpoint risk. Population-based modeling captures variability across multiple electrophysiological measures from healthy, disease, and drug phenotypes. We pursued optimizing therapeutic targets by identifying coherent sets of ion channel target modulations for recovering heterogeneous wild-type (WT) population excitability profiles from a heterogeneous Huntington's disease (HD) population. Our approach combines mechanistic simulations with population modeling of striatal neurons using evolutionary optimization algorithms to design 'virtual drugs'. We introduce efficacy metrics to score populations and rank virtual drug candidates. We found virtual drugs using heuristic approaches that performed better than single target modulators and standard classification methods. We compare a real drug to virtual candidates and demonstrate a novel in silico triaging method.